The efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression

British Journal of Nutrition

Volumn 104, Issue 11, 2010, Pages 1577-1585

  Jans, Linda A W ^a   Giltay, Erik J ^b   Willem Van Der Does, A J ^a,b  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fish oil; Meta analysis; n 3 PUFA; Perinatal depression

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ALPHA TOCOPHEROL; ARACHIDONIC ACID; CORN OIL; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; PLACEBO;

CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; FATTY ACID BLOOD LEVEL; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PERINATAL DEPRESSION; PSYCHOTHERAPY; REVIEW; SYSTEMATIC REVIEW;

DEPRESSION; DEPRESSION, POSTPARTUM; DIETARY FATS; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 78649984918     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510004125     Document Type: Review

References (50)

1. Das UN (2008) Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease - but how and why? Prostaglandins Leukot Essent Fatty Acids 78, 11-19.
2. Kidd PM (2007) Omega-3 DHA and EPA for cognition, behavior, and mood: Clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev 12, 207-227.
3. Su KP (2009) Biological mechanism of antidepressant effect of omega-3 fatty acids: How does fish oil act as a 'mind-body interface'? Neurosignals 17, 144-152.
4. Salem N Jr, Litman B, Kim HY, et al. (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36, 945-959.
5. Valenzuela A (2009) Docosahexaenoic acid (DHA), an essential fatty acid for the proper functioning of neuronal cells: Their role in mood disorders. Grasas Y Aceites 60, 203-212.
6. Farooqui AA, Ong WY & Horrocks LA (2006) Inhibitors of brain phospholipase A2 activity: Their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58, 591-620.
7. Edwards R, Peet M, Shay J, et al. (1998) Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 48, 149-155.
8. Hibbeln JR (1998) Fish consumption and major depression. Lancet 351, 1213.
9. Tanskanen A, Hibbeln JR, Tuomilehto J, et al. (2001) Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 52, 529-531.
10. Adams PB, Lawson S, Sanigorski A, et al. (1996) Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31, S157-S161.
11. McNamara RK, Hahn CG, Jandacek R, et al. (2007) Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 62, 17-24.
12. Peet M, Murphy B, Shay J, et al. (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43, 315-319.
13. Nemets B, Stahl Z & Belmaker RH (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159, 477-479.
14. Peet M & Horrobin DF (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59, 913-919.
15. Su KP, Huang SY, Chiu CC, et al. (2003) Omega-3 fatty acids in major depressive disorder. A preliminary doubleblind, placebo-controlled trial. Eur Neuropsychopharmacol 13, 267-271.
16. Freeman MP, Hibbeln JR, Wisner KL, et al. (2006) Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954-1967.
17. Lin PY & Su KP (2007) A meta-analytic review of doubleblind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68, 1056-1061.
18. Marangell LB, Martinez JM, Zboyan HA, et al. (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160, 996-998.
19. Rogers PJ, Appleton KM, Kessler D, et al. (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: A randomised controlled trial. Br J Nutr 99, 421-431.
20. Silvers KM, Woolley CC, Hamilton FC, et al. (2005) Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 72, 211-218.
21. Al MD, van Houwelingen AC, Kester AD, et al. (1995) Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr 74, 55-68.
22. Holman RT, Johnson SB & Ogburn PL (1991) Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci U S A 88, 4835-4839.
23. Otto SJ, van Houwelingen AC, Badart-Smook A, et al. (2001) Comparison of the peripartum and postpartum phospholipid polyunsaturated fatty acid profiles of lactating and nonlactating women. Am J. Clin Nutr 73, 1074-1079.
24. Al MD, van Houwelingen AC & Hornstra G (2000) Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J. Clin Nutr 71, 285S-291S.
25. Hibbeln JR & Salem N Jr (1995) Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy. Am J. Clin Nutr 62, 1-9.
26. Evans J, Heron J, Francomb H, et al. (2001) Cohort study of depressed mood during pregnancy and after childbirth. BMJ 323, 257-260.
27. O'Hara MW & Swain AM (1996) Rates and risk of postpartum depression - a meta-analysis. Int Rev Psychiatry 8, 37-54.
28. Makrides M, Neumann MA & Gibson RA (1996) Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr 50, 352-357.
29. Hibbeln JR (2002) Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: A cross-national, ecological analysis. J Affect Disord 69, 15-29.
30. Golding J, Steer C, Emmett P, et al. (2009) High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology 20, 598-603.
31. De Vriese SR, Christophe AB & Maes M (2003) Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: Further evidence that lowered n-PUFAs are related to major depression. Life Sci 73, 3181-3187.
32. Browne JC, Scott KM & Silvers KM (2006) Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression. J Affect Disord 90, 131-139.
33. Miyake Y, Sasaki S, Yokoyama T, et al. (2006) Risk of postpartum depression in relation to dietary fish and fat intake in Japan: The Osaka Maternal and Child Health Study. Psychol Med 36, 1727-1735.
34. Strom M, Mortensen EL, Halldorsson TI, et al. (2009) Fish and long-chain n-3 polyunsaturated fatty acid intakes during pregnancy and risk of postpartum depression: A prospective study based on a large national birth cohort. Am J. Clin Nutr 90, 149-155.
35. Mattes E, McCarthy S, Gong G, et al. (2009) Maternal mood scores in mid-pregnancy are related to aspects of neonatal immune function. Brain Behav Immun 23, 380-388.
36. Krauss-Etschmann S, Shadid R, Campoy C, et al. (2007) Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: A European randomized multicenter trial. Am J. Clin Nutr 85, 1392-1400.
37. Chiu CC, Huang SY, Shen WW, et al. (2003) Omega-3 fatty acids for depression in pregnancy. Am J Psychiatry 160, 385.
38. Freeman MP, Hibbeln JR, Wisner KL, et al. (2006) Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 113, 31-35.
39. Freeman MP, Hibbeln JR, Wisner KL, et al. (2006) An open trial of omega-3 fatty acids for depression in pregnancy. Acta Neuropsychiatrica 18, 21-24.
40. Marangell LB, Martinez JM, Zboyan HA, et al. (2004) Omega-3 fatty acids for the prevention of postpartum depression: Negative data from a preliminary, open-label pilot study. Depress Anxiety 19, 20-23.
41. Doornbos B, van Goor SA, Dijck-Brouwer DA, et al. (2009) Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuropsychopharmacol Biol Psychiatry 33, 49-52.
42. Freeman MP, Davis M, Sinha P, et al. (2008) Omega-3 fatty acids and supportive psychotherapy for perinatal depression: A randomized placebo-controlled study. J Affect Disord 110, 142-148.
43. Llorente AM, Jensen CL, Voigt RG, et al. (2003) Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 188, 1348-1353.
44. Rees AM, Austin MP & Parker GB (2008) Omega-3 fatty acids as a treatment for perinatal depression: Randomized double-blind placebo-controlled trial. Aust N Z J Psychiatry 42, 199-205.
45. Su KP, Huang SY, Chiu TH, et al. (2008) Omega-3 fatty acids for major depressive disorder during pregnancy: Results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 69, 644-651.
46. Dunstan JA, Mori TA, Barden A, et al. (2004) Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr 58, 429-437.
47. Freeman MP, Hibbeln JR, Wisner KL, et al. (2006) Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954-1967.
48. Appleton KM, Hayward RC, Gunnell D, et al. (2006) Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systematic review of published trials. Am J. Clin Nutr 84, 1308-1316.
49. Appleton KM, Rogers PJ & Ness AR (2010) Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J. Clin Nutr 91, 757-770.
50. Thase ME (1999) How should efficacy be evaluated in randomized clinical trials of treatments for depression? J Clin Psychiatry 60, Suppl. 4, 23-31.